Allianz Asset Management
RARE icon

Allianz Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,700
Closed -$408K 1814
2024
Q4
$408K Sell
9,700
-14,300
-60% -$602K ﹤0.01% 1461
2024
Q3
$1.33M Buy
24,000
+13,600
+131% +$755K ﹤0.01% 1185
2024
Q2
$427K Sell
10,400
-2,800
-21% -$115K ﹤0.01% 1456
2024
Q1
$616K Sell
13,200
-7,000
-35% -$327K ﹤0.01% 1360
2023
Q4
$966K Buy
20,200
+11,700
+138% +$559K ﹤0.01% 1230
2023
Q3
$303K Hold
8,500
﹤0.01% 1555
2023
Q2
$392K Buy
+8,500
New +$392K ﹤0.01% 1357
2022
Q3
Sell
-25,495
Closed -$1.52M 1625
2022
Q2
$1.52M Sell
25,495
-10,365
-29% -$619K ﹤0.01% 1369
2022
Q1
$2.6M Buy
35,860
+2,672
+8% +$194K ﹤0.01% 1300
2021
Q4
$2.79M Sell
33,188
-10,173
-23% -$856K ﹤0.01% 1304
2021
Q3
$3.91M Buy
43,361
+24,799
+134% +$2.24M ﹤0.01% 1171
2021
Q2
$1.77M Buy
18,562
+418
+2% +$39.9K ﹤0.01% 1330
2021
Q1
$2.07M Sell
18,144
-462
-2% -$52.6K ﹤0.01% 1260
2020
Q4
$2.58M Buy
18,606
+4,740
+34% +$656K ﹤0.01% 1229
2020
Q3
$1.14M Buy
13,866
+938
+7% +$77.1K ﹤0.01% 1372
2020
Q2
$1.01M Buy
+12,928
New +$1.01M ﹤0.01% 1420
2019
Q2
Sell
-31,364
Closed -$2.18M 2271
2019
Q1
$2.18M Buy
31,364
+12,431
+66% +$862K ﹤0.01% 1533
2018
Q4
$823K Buy
+18,933
New +$823K ﹤0.01% 1731
2017
Q3
Sell
-5,701
Closed -$354K 2106
2017
Q2
$354K Sell
5,701
-857
-13% -$53.2K ﹤0.01% 1936
2017
Q1
$445K Sell
6,558
-2,001
-23% -$136K ﹤0.01% 1887
2016
Q4
$602K Sell
8,559
-11,029
-56% -$776K ﹤0.01% 1804
2016
Q3
$1.39M Buy
+19,588
New +$1.39M ﹤0.01% 1603
2016
Q2
Sell
-103,933
Closed -$6.58M 2041
2016
Q1
$6.58M Sell
103,933
-44,257
-30% -$2.8M 0.01% 1063
2015
Q4
$16.7M Sell
148,190
-29,724
-17% -$3.35M 0.02% 722
2015
Q3
$17.1M Buy
177,914
+57,289
+47% +$5.52M 0.02% 696
2015
Q2
$12.4M Buy
120,625
+86,625
+255% +$8.87M 0.01% 863
2015
Q1
$2.11M Buy
+34,000
New +$2.11M ﹤0.01% 1235